Kiniksa Pharmaceuticals International (KNSA) Stock Price & Financial Analysis
Kiniksa Pharmaceuticals International Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Kiniksa Pharmaceuticals International
What is the current stock price for KNSA?
As of the latest trading session, KNSA stock trades at $56.89. The 52-week range is $26.27–$61.12, with a day range of $56.86–$59.73.
What is the P/E ratio for KNSA?
Kiniksa Pharmaceuticals International's trailing P/E ratio is 64.2, meaning investors pay $64.2 for every $1 of annual earnings. Kiniksa Pharmaceuticals International operates in the Healthcare sector.
Does KNSA pay dividends?
Kiniksa Pharmaceuticals International does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for KNSA?
Based on 7 analysts, the consensus for KNSA is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of KNSA?
Kiniksa Pharmaceuticals International's market capitalization is $4.69B, classifying it as a mid-cap company. Kiniksa Pharmaceuticals International operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.